24247-77-6

Basic information

• Product Name: Cyclohexanamine, 2,2-dimethyl-
• Synonyms: .2,2-dimethylcyclohexanamine;2,2-Dimethyl-cyclohexylamin;2,2-Dimethylcyclohexanamine;.2,2-dimethylcyclohexylamine;.2,2-Dimethylcyclohexylamin
• CAS NO: 24247-77-6
• Molecular Formula: C8H17N
• Molecular Weight: 127.23
• Mol File: 24247-77-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Cyclohexanamine, 2,2-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanamine, 2,2-dimethyl-(24247-77-6)
• EPA Substance Registry System: Cyclohexanamine, 2,2-dimethyl-(24247-77-6)

Safety Data

• Hazardous Substances Data: 24247-77-6(Hazardous Substances Data)

Upstream product

• 1193-47-1 2,2-dimethyl-cyclohexanone 
• 4500-17-8 2,2-dimethylcyclohexanone oxime 
• 4500-17-8 (E)-2,2-dimethylcyclohexanone oxime 
• 540-69-2 ammonium formate 
• 77287-34-4 formamide 

Downstream Products

• 103906-15-6 (2,2-dimethyl-cyclohexyl)-dimethyl-amine 
• 99064-86-5 N-(2,2-Dimethyl-cyclohexyl)-formamid 
• 69618-99-1 N-(2,2-dimethyl-cyclohexyl)-N-nitroso-glycine 
• 69618-97-9 (2,2-Dimethylcyclohexyl)hydrazin 
• 90726-09-3 2-Methylamino-1,1-dimethyl-cyclohexan 
• 69619-00-7 3-(1,1-dimethyl-cyclohexyl)-sydnone 
• 1357396-48-5 C₂₁H₂₉N₃O₄S 

Relevant articles and documents

PYRROLOPYRAZINE DERIVATIVES AS SYK AND JAK INHIBITORS

The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula (I), wherein the variables Q and R1 and R2 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.